Atlas Trials

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Clinical trial NCT00030082 · COMPLETED

Trial details

NCT number
NCT00030082
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Liver CancerMetastatic Cancer
Start date
2001-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.